Premier Medicine L L C v. U S Dept of Justice

CourtDistrict Court, W.D. Louisiana
DecidedJanuary 20, 2021
Docket5:19-cv-01352
StatusUnknown

This text of Premier Medicine L L C v. U S Dept of Justice (Premier Medicine L L C v. U S Dept of Justice) is published on Counsel Stack Legal Research, covering District Court, W.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Premier Medicine L L C v. U S Dept of Justice, (W.D. La. 2021).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA SHREVEPORT DIVISION

PREMIER MEDICINE LLC, ET AL. CIVIL ACTION NO. 19-1352

VERSUS JUDGE ELIZABETH E. FOOTE

UNITED STATES DEPARTMENT OF MAGISTRATE JUDGE HAYES JUSTICE, ET AL.

MEMORANDUM RULING

Before the Court is Defendants’ motion to dismiss and Plaintiffs’ motion to amend their complaint. Record Documents 16 and 18. Plaintiffs opposed Defendants’ motion to dismiss and Defendants replied. Record Documents 19 and 25. Defendants opposed Plaintiffs’ motion to amend their complaint on the grounds that the amendment is futile. Record Document 23. Both motions are ripe for review and, because they are interrelated, the Court will consider them together. For the reasons stated herein, Plaintiffs’ motion to amend [Record Document 18] is GRANTED and Defendants’ motion to dismiss [Record Document 16] is also GRANTED. I. Background Plaintiffs, Premier Medicine, LLC (“Premier”) and Patrick H. Deere, M.D. (“Deere”), filed suit in Louisiana state court against Defendants, Theresa A. Bass (“Bass”), Bradford Byerly (“Byerly”), the United States Department of Justice, Drug Enforcement Agency (“DEA”), and the Louisiana State Board of Medical Examiners (“Board”). Record Document 6-1 at 3. In their complaint, Plaintiffs state that Premier owns a medical facility called Ketamine IV Infusion and Nutrient IV Drop Medical Clinic and that Deere is the clinic’s lead physician. They allege that prior to opening the clinic, they contacted the Board and were

informed that a licensed physician was not required to be on the premises while administering Ketamine treatment to patients. at 4. Plaintiffs do not allege that they were given written documentation of this advice. They do allege that they attempted to confirm that the clinic was in compliance with all state and federal regulations for administering Ketamine by contacting Bass, a Diversion Investigator for the DEA. After several weeks, nobody at the DEA had responded to Plaintiffs’ inquiries, and they opened

the clinic believing they were in full compliance with the law. at 5. Plaintiffs state that on August 19, 2019, Bass—acting at all times in the scope and course of her employment at the DEA and under the direction of Byerly, a Special Agent in Charge for the DEA—came to the clinic, presented Plaintiffs with a “Stop Operations Order,” instructed them to immediately cease all infusions, and seized forty-eight vials of unopened Ketamine and twenty-five vials of Midazolam. These medications belonged to Deere and were “issued under his Physician Profile Card #FD8313645” (“Physician

Profile Card”) for use at the clinic. . Plaintiffs contend that Bass informed them that a doctor was required to be on site during all Ketamine treatments and “pressured” Deere to sign a “ of his Physician Profile Card.” at 5-6. Plaintiffs filed suit in state court alleging that Deere’s Physician Profile Card was unjustly taken under false pretenses and without being provided any documentation of their alleged violations or formal charges that they violated any rules, regulations, or guidelines. at 6. They also allege that Defendants violated their due process rights under Article I, Section 2 of the Louisiana Constitution. at 14. Plaintiffs seek monetary

damages for their lost revenue while the clinic is unable to administer treatment and an injunction ordering that Deere’s Physician Profile Card be returned and that the clinic be allowed to resume treatments. at 6-9. The DEA, Bass, and Byerly removed the case to federal court. Record Document 1. Subsequent to this, the Board was dismissed from the suit, leaving only the DEA, Bass, and Byerly as Defendants. Record Document 14. Defendants then filed the motion to

dismiss currently pending before the Court. Record Document 16. They argue that the Court lacks subject matter jurisdiction over Plaintiffs’ claims for a variety of reasons, including that this Court lacks jurisdiction because the state court lacked jurisdiction, that the United States has not waived sovereign immunity for these claims, and that Plaintiffs failed to exhaust administrative remedies. Record Document 16-1. They also contend that in the event the Court finds that it has jurisdiction over some or all of Plaintiffs’ claims, Plaintiffs have failed to state a due process claim because they did not allege any facts

to support their contention that Deere involuntarily signed a waiver of his due process rights. Record Document 16-1 at 23-25. In response, Plaintiffs sought leave to amend their complaint. Record Document 18. The proposed second amended complaint brings suit against Bass and Byerly in their official and individual capacities, alleges that their suit is authorized by the Federal Tort Claims Act, and alleges that Plaintiffs’ federal constitutional due process rights were violated in addition to their state due process rights. Record Document 18-1. Plaintiffs oppose Defendant’s motion to dismiss by arguing that their second amended complaint now identifies a statute under which the United States has waived its sovereign immunity,

that administrative exhaustion is not necessary as they bring suit against Bass and Byerly in their individual capacities, and that their due process claim cannot be dismissed at this time because whether Deere voluntarily waived his rights “is a substantive and fact- dependent question.” Record Document 19. Defendants oppose Plaintiffs’ motion to amend on the ground that the amended complaint is futile because, even as amended, it is subject to dismissal. Record Document 23.

II. Plaintiffs’ Motion to Amend As set forth above, in response to Defendants’ motion to dismiss, Plaintiffs filed a motion to amend their complaint. Record Document 18. Plaintiffs state that the motion was filed “out of an abundance of caution” because, while Plaintiffs had not amended their complaint in federal court, they had supplemented their complaint once in state court prior to removal. at 2. Federal Rule of Civil Procedure 81(c)(1) provides that the Federal Rules of Civil

Procedure “apply to a civil action after it is removed from a state court.” Under Rule 15, a plaintiff is entitled to amend his or her complaint “once as a matter of course” under several circumstances, including within “21 days after service of a motion under Rule 12(b).” Fed. R. Civ. P. 15(a)(1)(B). Thus, Plaintiffs are allowed to amend their complaint once as a matter of course within twenty-one days of Defendant’s motion to dismiss being filed. They did so, though by motion to ensure that they complied with procedural rules. Because the Court finds that Plaintiffs had the right to amend their complaint without leave of court, the motion to amend is GRANTED. III. Defendants’ Motion to Dismiss

Generally, when a plaintiff files an amended complaint, any pending motions to dismiss become moot. , No. EP-16-CV-41-DB, 2016 WL 8674378, at *1 (W.D. Tex. June 16, 2016) (collecting cases). In this case, however, Defendants contend that Plaintiffs’ second amended complaint failed to remedy the jurisdictional defects identified in their motion to dismiss. Because the subject matter jurisdiction challenge persists and courts are obligated to address such issues, even

at times, the Court will consider this issue. , 243 F.3d 912, 919 (5th Cir. 2001) (“[F]deral courts must address jurisdictional questions whenever they are raised and must consider jurisdiction if not raised by the parties.”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Howery v. Allstate Ins Company
243 F.3d 912 (Fifth Circuit, 2001)
Gibson v. Federal Bureau of Prisons
121 F. App'x 549 (Fifth Circuit, 2004)
Dorsey v. Portfolio Equities, Inc.
540 F.3d 333 (Fifth Circuit, 2008)
McCarthy v. Mukasey
555 F.3d 459 (Fifth Circuit, 2009)
Armstrong v. Manzo
380 U.S. 545 (Supreme Court, 1965)
Fuentes v. Shevin
407 U.S. 67 (Supreme Court, 1972)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Hafer v. Melo
502 U.S. 21 (Supreme Court, 1991)
Federal Deposit Insurance v. Meyer
510 U.S. 471 (Supreme Court, 1994)
Lane v. Pena
518 U.S. 187 (Supreme Court, 1996)
Correctional Services Corp. v. Malesko
534 U.S. 61 (Supreme Court, 2001)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Lanny Walters v. Donald Smith
409 F. App'x 782 (Fifth Circuit, 2011)
RANDALL D. WOLCOTT, MD, PA v. Sebelius
635 F.3d 757 (Fifth Circuit, 2011)
Life Partners Inc. v. United States
650 F.3d 1026 (Fifth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Premier Medicine L L C v. U S Dept of Justice, Counsel Stack Legal Research, https://law.counselstack.com/opinion/premier-medicine-l-l-c-v-u-s-dept-of-justice-lawd-2021.